Article
Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
British journal of cancer - 1 Oct 2023
Magnusson Magnus I, Agnarsson Bjarni A, Jonasson Jon G, Tryggvason Thordur, Aeffner Famke, le Roux Louise, Magnusdottir Droplaug N, Gunnarsdottir Helga S, Alexíusdóttir Kristín K, Gunnarsdottir Kristbjorg, Söebech Emilia, Runarsdottir Hjaltey, Jonsdottir Erna M, Kristinsdottir Bjarney S, Olafsson Sigurgeir, Knutsdottir Hildur, Thorsteinsdottir Unnur, Ulfarsson Magnus O, Gudbjartsson Daniel F, Saemundsdottir Jona, Magnusson Olafur T, Norddahl Gudmundur L, Watson J E Vivienne, Rafnar Thorunn, Lund Sigrun H, Stefansson Kari
Abstract excerpt
BACKGROUND: The TNM system is used to assess prognosis after colorectal cancer (CRC) diagnosis. Other prognostic factors reported include histopathological assessments of the tumour, tumour mutations and proteins in the blood. As some of these factors are strongly correlated, it is important to evaluate the independent effects they may have on survival. METHODS: Tumour samples from 2162 CRC patients were visually...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.